Bluebird gene therapy shows promise for lethal blood disease By: MarketWatch December 09, 2014 at 07:15 AM EST Shares soar after news that four patients were able to forgo life-sustaining blood transfusions after treatment. Read More >> Related Stocks: Bluebird Bio